MACSF

COMMUNIQUÉS West-GlobeNewswire

Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine
09/07/2025
The previously disclosed and now published RESILIENT data show that once-nightly TNX-102 SL achieved statistically significant improvement in the primary endpoint of reducing fibromyalgia pain versus placebo, and was [...]
Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis
09/07/2025
Data from Orbit and Cosmic studies expected around the end of the year NOVATO, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO), today [...]
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/07/2025
SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies [...]
Inventiva annonce la nomination de Jason Campagna en tant que Président de la R&D et Directeur Médical et de Martine Zimmermann en tant que Vice-Présidente Exécutive en charge des affaires réglementaires et de l’assurance qualité
09/07/2025
Jason Campagna, MD, PhD, rejoint Inventiva en tant que Président de la R&D et Directeur Médical, succédant à Pierre Broqua, PhD, et Michael Cooreman, MD Martine Zimmermann, PharmD, rejoint l'entreprise en tant que [...]
Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance
09/07/2025
Jason Campagna, MD, PhD, joins Inventiva as President of R&D and Chief Medical Officer, succeeding Pierre Broqua, PhD, and Michael Cooreman, MD Martine Zimmermann, PharmD, joins as Executive Vice President of [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
09/07/2025
ZUG, Switzerland, July 09, 2025 (GLOBE NEWSWIRE) -- The attached notification relates to the vesting and settlement of RSUs previously granted to directors of the Company. Attachment Notification of managers' [...]
Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025
09/07/2025
RADNOR, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2025 [...]
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
09/07/2025
BOSTON, July 09, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare [...]
GUERBET : Bilan semestriel du contrat de liquidité
09/07/2025
Bilan semestriel du contrat de liquidité Villepinte, le 9 juillet 2025 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, présente aujourd’hui le bilan [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2025
09/07/2025
Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2025 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2025
09/07/2025
Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2025 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Press release: Transparency Notification from Shareholders
09/07/2025
Transparency Notification from Shareholders Ghent, Belgium – 9 July 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the treatment of drug-resistant fluid [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juin 2025
09/07/2025
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Sanofi: Information concerning the total number of voting rights and shares - June 2025
09/07/2025
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
HOOPP announces changes to its Executive Leadership Team
09/07/2025
TORONTO, July 09, 2025 (GLOBE NEWSWIRE) -- Today, the Healthcare of Ontario Pension Plan (HOOPP) is pleased to announce changes to its executive leadership team. Linda Halley has been promoted to Chief Risk Officer. [...]
OrganOx Honoured as Winner of the 2025 MacRobert Award for UK Engineering Innovation
09/07/2025
OXFORD, United Kingdom and MADISON, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, has been announced as the winner of the prestigious 2025 MacRobert Award by the Royal [...]
TerrAscend Completes $79 Million Non-Dilutive Debt Financing
09/07/2025
Proceeds used to retire $68 million of existing debt with the remainder designated for future growth initiatives Additional facility of up to $35 million available for strategic M&A No material debt maturing until [...]
Benitec Biopharma Provides Operational Updates
09/07/2025
-In April 2025 the Sixth and Final Subject of Cohort 1 was Safely Treated with the Low Dose of BB-301 in the Phase 1b/2a Clinical Treatment Study (NCT06185673)- -Independent Data Safety Monitoring Board Review Has Been [...]
FluidForm Bio™ Presents Six-Month Efficacy Data of FRESH 3D Bioprinted Human Islet Subcutaneous Scaffolds at the American Diabetes Association (ADA) 85th Scientific Sessions
09/07/2025
Presentation also given at the 20th World Congress of the International Pancreas & Islet Transplant Association (IPITA) WALTHAM, Mass., July 09, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies [...]

Pages